Intact IGFBP-4 ELISA by Ansh Labs

Manufacturer Ansh Labs  |   Model: AL-128  |  Available Worldwide
Several studies have shown that concentration of PAPP-A in blood of patients with acute coronary syndrome (ACS) is higher than in blood of patients with stable coronary artery disease or control subjects. PAPP-A has been suggested as a marker of cardiovascular diseases associated with coronary artery blood clotting, such as unstable angina and myocardial infarction (MI). 


Intact IGFBP-4 ELISA by Ansh Labs product image
Intact IGFBP-4 ELISA
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

Several studies have shown that concentration of PAPP-A in blood of patients with acute coronary syndrome (ACS) is higher than in blood of patients with stable coronary artery disease or control subjects. PAPP-A has been suggested as a marker of cardiovascular diseases associated with coronary artery blood clotting, such as unstable angina and myocardial infarction (MI). The ratio of Total to Intact IGFBP-4 concentration measured in individual subjects over time will help normalize the IGFBP-4 variability between subjects and also increase the detection rate of increased PAPP-A activity in myocardial infarction subjects.

The Ansh Labs' Intact IGFBP-4 ELISA is a quantitative three-step sandwich immunoassay. The ratio of Total to Intact IGFBP-4 concentration measured in individual subjects will help normalizes the variability between subjects and also increase the detection rate of increased PAPP-A activity in myocardial infarction subjects. Useful in research related to cancer studies, hypertension, diabetes, cardiomyopathy, osteoarthritis, aging and longevity studies, and growth hormone deficiency.

  • The monoclonal antibody pair used detects intact IGFBP-4
  • The capture antibody binds to the N terminal of the molecule whereas detection antibody binds to C terminal
  • The assay does not cross-react to IGF-I, rat IGF-I, IGFBP-3, IGFBP-3/IGF-1 complex and IGFBP-2 at 1000 ng/ml concentration
  • The assay also detects bovine and equine
  • Analytical range of 7 – 1200 ng/mL
  • Simple procedure with no sample preparation
  • Total 2 hr incubation at RT. Sensitive to 1.62 ng/mL

Research Use Only within the United States.